Biological systems rely on enzymes such as kinases to transmit information between the nodes of cell-signaling networks, often to transduce extracellular ligand-binding events into intracellular information. An important example of this is found in T cells, an essential cell type of our adaptive immune system that can discriminate between healthy cells and those that are infected by pathogens. Expression of the TCR complex at the cell surface allows the T cell to probe potentially infected host cells by scrutinizing their surface for expression of peptide fragments of pathogens presented within the MHC protein (pMHC). Upon TCR binding to cognate pMHC, a cascade of intracellular signaling is initiated from the TCR that leads to the T cell either directly killing the infected cells or instructing other cell-types to do so 1 .
Biological systems rely on enzymes such as kinases to transmit information between the nodes of cell-signaling networks, often to transduce extracellular ligand-binding events into intracellular information. An important example of this is found in T cells, an essential cell type of our adaptive immune system that can discriminate between healthy cells and those that are infected by pathogens. Expression of the TCR complex at the cell surface allows the T cell to probe potentially infected host cells by scrutinizing their surface for expression of peptide fragments of pathogens presented within the MHC protein (pMHC). Upon TCR binding to cognate pMHC, a cascade of intracellular signaling is initiated from the TCR that leads to the T cell either directly killing the infected cells or instructing other cell-types to do so 1 .
The most proximal event following pMHC binding is the phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) in the intracellular tails of the TCR by LCK, a prototypic member of the SRC-family tyrosine kinases (SFK) that is almost exclusively expressed in T cells 2 . The phosphorylated ITAMs then recruit proteins with SRC-homology 2 (SH2) domains, such as ZAP70, a cytoplasmic tyrosine kinase. Bound ZAP70 is phosphorylated by LCK, primarily at tyrosine 319 (Y319), which leads to its activation and subsequent phosphorylation of downstream effector molecules that drive multiple signaling pathways. LCK kinase activity is therefore crucial in translating the TCR-pMHC interaction into intracellular signals in T cells. Understanding how the kinase activity of LCK is controlled within T cells at the molecular level is important not only for our fundamental understanding of TCR signal transduction but for suggesting new means by which its activity could be modulated therapeutically, given the deleterious effect of T-cell-mediated autoimmunity 3 and its aberrant regulation in certain leukemias 4, 5 .
Previous studies have shown that the SH2 domain of LCK can bind intramolecularly to a phosphorylated residue (Y505) at the C terminus to adopt a closed autoinhibitory conformation, which is a general feature of the SFK regulatory mechanism 6, 7 . Phosphorylation of Y505 is catalyzed by C-terminal SRC kinase (CSK) 8, 9 and antagonized primarily by the membrane-bound tyrosine phosphatase CD45 (ref. 10 ). This modification can regulate the conformations that LCK can adopt, affecting its activity [11] [12] [13] . Full activation of LCK also requires phosphorylation at Y394 in the activation loop of the kinase domain 14, 15 . In addition, LCK can be bound by the T-cell coreceptors CD4 and CD8, transmembrane proteins that can both bind to the MHC protein 16 and engage with LCK 17,18 through a Zn 2+ 'clasp' 19 . The functional effect of the coreceptors on T-cell signaling has been extensively studied during thymocyte development 16 , but it remains unclear whether they have a direct influence on LCK kinase activity.
Current in vitro methods used to investigate how LCK, or indeed any SFK, functions at the molecular level invariably depend on assaying its kinase activity after removal from the cellular environment. Experiments are invariably performed in solution on nonphysiological substrates that are unlikely to faithfully replicate kinase function when normally constrained to the plasma membrane. Authors of a recent study did address this latter issue by tethering LCK to lipid vesicles 14 , but this accomplishment required altering the N-terminal structure of the kinase to anchor it to the bilayer.
Conversely, most in vivo studies of LCK function have been limited by the inability to initiate kinase activity directly and so normally rely on steady-state measures of catalytic activity that do not provide the quantitative detail required for a mechanistic understanding. Recent methods have been designed to address this limitation, principally by inserting chemically-or optically-controlled domains into kinases to 1 1 5 6 VOLUME 24 NUMBER 12 DECEMBER 2017 nature structural & molecular biology a r t i c l e s allosterically modulate activity [20] [21] [22] . This approach has found some success, although not with LCK, but all of these methods require extensive alterations to the native kinase structure that could interfere sterically with potential protein interactions and may not represent the 'true' kinase in situ.
Encoding new functionality at specific sites of a protein when expressed in cells through the use of genetically encoded unnatural amino acid incorporation 23, 24 has enabled the in vivo control of protein function with a precision more commonly associated with in vitro approaches 25 . By combining this approach with a cellular reconstitution of proximal TCR triggering with defined components 26 , we have developed a direct and quantitative method to assay the kinase activity of native LCK within the cellular environment. Engineering LCK so that its catalytic activity can be spatiotemporally controlled within live cells by brief light stimulation provides a new platform for 'in vivo biochemistry' , which we use to show that LCK is critically dependent on Y394 phosphorylation in its active-site loop for its kinase activity and that the T-cell coreceptors can enhance LCK function at limiting kinase levels.
RESULTS

Engineering a photocaged LCK kinase using unnatural amino acid incorporation
To quantitatively investigate LCK kinase function when localized in the plasma membrane of live cells, we needed precise temporal control over the initiation of its enzymatic activity. We noted that lysine at position 273 (K273) in the active site of human LCK is essential for its enzymatic activity, where mutation of this residue disrupts ATP binding and substrate phosphate transfer 27 . We anticipated that engineering control of substrate binding at this position would provide a mechanism to modulate LCK kinase activity. We used unnatural amino acid (UAA) mutagenesis to genetically incorporate a photocaged variant of lysine (pc-Lys) at K273, which can be rapidly uncaged under ultraviolet (~350-400 nm) illumination, leaving a scarless lysine residue 25, 28 (Fig. 1a) . The pc-Lys residue can be easily accommodated in the active site of LCK without alteration to the kinase structure and is expected to sterically occlude ATP binding (Supplementary Fig. 1a) .
Using the UAA system optimized for efficient incorporation in mammalian cells 25, 29 , we expressed human LCK fused to eGFP with a r t i c l e s the codon for K273 mutated to the amber stop codon (LCK K273-TAG ) in HEK-293T cells. Cells were transfected with all of the components required for UAA incorporation, as well as ZAP70 kinase fused to the mRuby2 fluorophore. Cells transfected in normal medium showed expression of ZAP70 alone, but the addition of pc-Lys led to the coexpression of photocaged LCK (LCK*) (Fig. 1b) . This finding confirmed that in the absence of pc-Lys, translation of LCK K273-TAG was efficiently terminated at the internal stop codon. We found that ~40% of ZAP70-expressing cells also incorporated pc-Lys into LCK* (Fig. 1c) , which localized correctly to the plasma membrane (Fig. 1d) . Western analysis using an anti-LCK antibody showed that LCK* was expressed at the expected molecular weight (Fig. 1e) .
To demonstrate that LCK* was inactive but could be rendered functional by illumination, we used HEK-293T cells stably expressing the complete TCR complex (HEK-TCR; Supplementary Fig. 2a ) and measured ZAP70 phosphorylation by LCK* upon illumination of the cells. We have previously shown that LCK shows constitutive activity toward the TCR and other downstream signaling molecules in HEK-293T 26 , owing to the near-complete absence of inhibitory proteins that normally restrain its activity (Supplementary Fig. 2b,c) . ZAP70 Y319 is a physiological substrate of LCK and is not associated with any ZAP70 autocatalytic mechanism 30, 31 , thereby making it a good readout for LCK kinase activity. We first optimized the length and intensity of the illumination to uncage pc-Lys in LCK* by measuring Y319 phosphorylation by phospho-western analysis (Fig. 1f) . Blot quantification showed that before illumination, no phosphorylation was detectable, but 30-s illumination at 12 mW/cm 2 uncaged LCK* sufficiently to cause phosphorylation 15 min post illumination without signal saturation (Fig. 1g) . This condition was preferred, as it limited any cytotoxic effects of high-intensity light and allowed us to capture the dynamic range of the phosphorylation events over the assay time course. Results from control experiments confirmed that the observed Y319 phosphorylation was specific to the activity of LCK* uncaged by 350-400-nm light illumination. Phosphorylation was not observed when a catalytically inactive variant of LCK (K273R) was equivalently illuminated or when LCK* was illuminated by different wavelengths of light (500-550 nm) (Supplementary Fig. 1b) .
Using this optimized system, we measured the kinetics of LCK* activity by quenching the phosphorylation reaction at various time points after pc-Lys uncaging. We then observed the expected increase in Y319 phosphorylation over time (Fig. 1h) , and a progress curve of the wild-type enzyme activity in live cells was plotted (Fig. 1i) .
In subsequent experiments, we decreased the density of time points to improve our throughput to analyze several LCK* variants simultaneously, which did not compromise the experimental results (Supplementary Fig. 3a) .
Phosphorylation of LCK active-site loop is essential for its kinase activity LCK, like many members of the tyrosine kinase family, has an activation loop within the kinase domain (Fig. 2a) that must be phosphorylated at a specific tyrosine residue to ensure full enzymatic activity. However, it remains unresolved whether the unphosphorylated form of LCK retains significant activity in vivo, given a recent in vitro study that showed only a two-fold increase in kinase activity when the active-site loop was phosphorylated 14 . We substituted the tyrosine in the activation loop of LCK with phenylalanine (Y394F), which will abolish its phosphorylation. We found that this substitution a r t i c l e s rendered the kinase essentially inactive (Fig. 2b,c) , which was not caused by the endogenous expression of the inhibitory kinase CSK by the HEK-TCR cells (Supplementary Fig. 3b ). This finding suggested that when not phosphorylated at Y394, LCK activity is almost completely absent when present in its native cellular environment. Conversely, the Y505F mutation in the C-terminal tail of LCK has been known to substantially increase its kinase activity 32, 33 by removing CSK-mediated phosphorylation of Y505 that drives intramolecular inhibition, and this is what we observed (Fig. 2d) . To provide a quantitative comparison between the LCK* variants, we derived the maximal reaction rate from the kinetic data, which should be proportional to the catalytic activity of the kinase, assuming equivalent enzyme and substrate concentrations. This data pointed to the Y505F mutant having an ~8-fold increased reaction rate compared to that of wild-type LCK*, whereas the reaction rate for the Y394F mutant was undetectable (Supplementary Fig. 3c ).
We used a complementary assay to provide further evidence for the complete inhibition of LCK in the absence of Y394 phosphorylation. Prior to Y319 phosphorylation, ZAP70 is recruited to the phosphorylated ITAMs of the TCR complex at the plasma membrane, an event that also depends on LCK activity. We used live-cell imaging of ZAP70 recruitment to the cell surface as an alternative means to probe LCK a r t i c l e s kinase activity toward the TCR. We used an equivalent transfection strategy to that described above but used HEK-TCR cells expressing higher TCR density (HEK-TCR H ) to increase the membrane signal ( Supplementary Fig. 2d ). As expected, ZAP70 was initially localized to the cytoplasm but rapidly translocated to the plasma membrane upon the uncaging of wild-type LCK* ( Fig. 2e and Supplementary Video 1). Quantitative image analysis measuring the relative fluorescence intensity of ZAP70 at the plasma membrane showed that it was efficiently recruited to the TCR (Fig. 2f) . The Y394F mutation of LCK* caused undetectable ZAP70 recruitment ( Fig. 2g and Supplementary Video 1). Conversely, the Y505F LCK* variant showed even faster dynamics ( Fig. 2h and Supplementary Video 1) , saturating ZAP70 binding within 20 s that subsequently decreased, presumably owing to deleterious effects of the overactive kinase on cell integrity, such as membrane blebbing (Supplementary Video 1) . Because the kinetics of ZAP70 recruitment to the membrane did not follow a simple profile, we quantified LCK* activity by determining the time required for half-maximal ZAP70 recruitment, with a shorter time corresponding to increased LCK* function ( Supplementary Fig. 3d ). The results from these imaging experiments are in strong agreement with the conclusions from the phospho-western experiments.
Intramolecular SH3 interaction restrains LCK kinase activity
The SH2 domain of LCK is known to interact not only with phosphorylated tyrosine motifs in other proteins but also with phosphorylated Y505 intramolecularly, which inhibits LCK activity. The generally agreed-upon explanation for why the Y505F mutation of LCK enhances catalytic activity compared to the wild-type kinase is the disruption of this intramolecular inhibition. We wanted to test whether the converse was true; does disrupting binding by the SH2 domain cause equivalent enhancement of LCK function? The R154K substitution in the SH2 domain of LCK is known to disable binding of this domain to phosphorylated polypeptides 34 . We anticipated that this mutation would mimic the Y505F mutant by releasing intramolecular inhibition. However, the R154K mutation significantly decreased ZAP70 Y319 phosphorylation to ~25% compared to that of the wild type ( Fig. 3a and Supplementary Fig. 3c ), thus implying that the SH2-domain interaction with binding partners, such as the TCR, is more critical to LCK function than its role in intramolecular inhibition.
The SH3 domain of LCK can also participate in intramolecular binding with the conserved proline-rich (PxxP) motif in the linker region, although this interaction is considerably less well characterized compared to the SH2 interaction. We expected that SH3-mediated intramolecular binding would also restrain LCK* kinase activity. We first disrupted a key residue (W97A) in the SH3 domain and found that LCK* kinase activity was substantially increased compared to that of wild-type LCK* (Fig. 3b) . This finding suggested that, at least within the transfected HEK-TCR cells, the primary function of the SH3 domain is to inhibit LCK kinase activity rather than to bind another target protein. A prediction from this result is that mutation of the proline-rich motif that interacts with the SH3 domain within LCK should have an equivalent effect on the activity of LCK. Through structural modeling of full-length human LCK based on a related kinase, we identified P232 within the conserved PxxP motif of LCK that should interact with W97 of the SH3 domain ( Supplementary  Fig. 3e ). Mutating this residue (P232A) dramatically increased LCK* kinase activity (Fig. 3c) . Both W97A and P232A substitutions led to an equivalent increase in LCK* activity that was quantitatively comparable to that of the Y505F mutant ( Fig. 3d and Supplementary  Fig. 3c) , suggesting that the primary function of the intramolecular SH3-mediated interaction is to restrain LCK catalytic activity.
LCK activation by autophosphorylation
It has been shown that Y394 in the activation loop of LCK is autophosphorylated in trans 12, 14, 35, 36 , but the kinetics of this reaction have not been studied in situ. To address this, we first investigated the kinetics of LCK* Y394 autophosphorylation following pc-Lys uncaging. We found that the process occurred at a much faster rate compared to that of ZAP70 Y319 phosphorylation (Fig. 4a) . To confirm that this rapid autophosphorylation was occurring predominantly in trans, we coexpressed wild-type LCK* and a catalytically-inactive variant of LCK (K273R) in cells and measured the phosphorylation of Y394 in both forms by LCK* (Fig. 4b) . Because LCK (K273R) is devoid of kinase activity, any phosphorylation observed could only have been attributed to the in trans activity of uncaged LCK*, which was indeed the case (Fig. 4c) . However, although the relative rates of Y394 autophosphorylation on both kinase variants were very similar, the absolute level of LCK (K273R) phosphorylation was much lower compared to that of uncaged LCK* (Fig. 4c) , which was not owing to differences in their expression (Fig. 4b) .
The preceding results suggested that the catalytically-inactive LCK (K273R) was less susceptible to autophosphorylation at Y394, perhaps by adopting a conformation in which Y394 was less accessible, compared to that of the uncaged LCK*. We tested this hypothesis by varying the illumination period used to uncage LCK*. Cells exposed to shorter illumination would have less uncaged, active LCK*. As predicted, shorter illumination led to a lower maximal pY394 signal compared to those of the samples that were illuminated for longer (Fig. 4d) . If the effect of different illumination periods was to only vary the level of LCK* as an active enzyme and not as a 'substrate' , there would have been differences in the rate of phosphorylation and not the maximal phosphorylation, but this is not what we observed. We hypothesized that because the Y505F LCK* mutant should be in a more 'open' conformation, it should have increased accessibility of Y394, which is exactly what we observed (Fig. 4e) .
ZAP70 depends on autophosphorylation for activation
Full activation of ZAP70 kinase requires phosphorylation of its activation loop at Y493, in an equivalent manner to that of LCK 37 . Although it is accepted that ZAP70 Y493 phosphorylation requires the presence of active LCK, it is less clear whether LCK itself directly phosphorylates a r t i c l e s Y493 (refs. 38,39) or whether this modification primarily relies on ZAP70 autophosphorylation 31 . We used our LCK* uncaging approach to follow the kinetics of ZAP70 phosphorylation at both Y319 and Y493. We found that LCK*-mediated Y319 phosphorylation had significantly faster kinetics than those of Y493 phosphorylation, with a delay evident between the initiation of ZAP70 Y319 and Y493 phosphorylation (Fig. 5a) . We speculated that this difference was due to Y493 phosphorylation being mediated by ZAP70 autophosphorylation rather than LCK*. To investigate this, we repeated the kinetic assay but included a kinase-dead version of ZAP70 (K369R). Compared to wildtype ZAP70, the catalytically inactive version had a far lower rate of Y493 phosphorylation (Fig. 5b) . The data show that the primary kinase responsible for ZAP70 Y493 phosphorylation is ZAP70 itself.
Activity of other SRC-family kinases expressed in T cells
There are nine members of the SFK family, but only three are expressed at significant levels in T cells: LCK, FYN and, to a lesser extent, SRC. Although both LCK and FYN play roles during early TCR signaling, it is believed that LCK is the major kinase involved in TCR-mediated signaling 40, 41 . To test whether this was because LCK was more efficient at initiating T-cell signaling, we constructed the photocaged versions of FYN and SRC by mutating the codons for K299 (FYN*) and K298 (SRC*) to the amber stop codon, in an equivalent manner as that for LCK*. We found that ZAP70 Y319 is phosphorylated by LCK* at a much greater rate when compared with FYN* or SRC* ( Supplementary  Fig. 4) , demonstrating that ZAP70 is a better substrate for LCK.
Spatial control of LCK activation using the photocaged system
To demonstrate that we could both spatially and temporally control LCK activation, we took advantage of a cell-cell conjugation system in which the TCR on the HEK cells interacted with its specific peptide (derived from NY-ESO) covalently bound into the MHC protein and expressed on the surface of Raji B cells, which act as efficient ligand-presenting cells 26 . The inhibitory proteins CD45 and CSK were also expressed in HEK-TCR H cells to prevent TCR triggering outside the conjugate interface, where cells adhere through coexpression of ICAM-1, which can interact with the integrin LFA-1 on Raji B cells and the TCR-pMHC interaction itself 26 . We uncaged LCK* by illuminating a diffraction-limited (<1 µm) region of the conjugate interface with a 405-nm laser beam, pulsed for 1 ms. This spatiotemporally localized activation of LCK* initially led to the recruitment of ZAP70 to only this region before increasing throughout the cell interface, presumably owing to the lateral diffusion of LCK* (Fig. 6  and Supplementary Video 2) . Fortuitously, the presented LCK*-expressing cell was conjugated to two separate B cells, which allowed us to confirm the spatial restriction of LCK* uncaging, because no ZAP70 was recruited to the untargeted conjugate interface (Fig. 6  and Supplementary Video 2) . To confirm that this conjugate region nonetheless had the potential to be activated, we subsequently used global illumination and observed ZAP70 recruitment to the second conjugate interface (Fig. 6) . This demonstrated that we could both spatially and temporally control LCK activation at subcellular and millisecond resolution in live cells.
Effect of CD4 and CD8 coreceptors on LCK function
It has been established that the T-cell coreceptors have a significant influence on thymocyte development and T-cell activation 16 , and the interaction between the cytosolic tails of the membrane-bound coreceptors and the SH4 domain of LCK (Fig. 2a) has been confirmed 19, 42 . In addition to the intracellular LCK interaction, the coreceptors bind the pMHC protein expressed on antigen-presenting cells. It remains uncertain whether the coreceptor's effect on LCK activity is mediated solely by influencing the localization, or dwell time, of the kinase at the engaged TCR complex, a question that we sought to directly address using the approaches described above. We first used our cell-conjugate assay to investigate how CD8 modulates LCK*-mediated ZAP70 membrane recruitment. LCK* uncaging caused the translocation of ZAP70 to the entire conjugate site (Fig. 7a and . Initially, a specific region of the upper conjugate (white arrow in overlay) was exposed to a focused 405-nm laser pulse to uncage LCK* in that region only, and ZAP70 recruitment to the region was observed over time. A second, global illumination was applied on the same cells to uncage the remaining LCK*. Subsequently, ZAP70 recruitment to the lower conjugate was observed (plus sign in ZAP70 image). Twenty cells were analyzed over three independent experiments that showed similar spatiotemporal control of LCK* kinase activity within individual conjugates. Scale bar, 5 µm.
a r t i c l e s Supplementary Video 3), the kinetics of which were quantified over many conjugates (Fig. 7b) . Repeating the assay using CD8 + HEK-TCR H cells (Supplementary Fig. 2e ) caused an increased rate of ZAP70 translocation following LCK* uncaging ( Fig. 7b and Supplementary Fig. 5a ). An equivalent CD4 assay was not possible because the TCR used is restricted by class-I MHC. CD8 could potentially enhance LCK activity by simply increasing the kinase density within the conjugate interface. We did indeed observe increased LCK* in this region compared to the rest of the plasma membrane, but this effect was not CD8 dependent (Fig. 7c,d) . Instructively, the lipid-modified N terminus of LCK alone (Myr-eGFP) was sufficient to replicate the increased LCK* density in the conjugate interface (Fig. 7c,d) , as was a prenylated eGFP (eGFP-CaaX), which suggested an alteration to the membrane lipid environment around the clustered TCR as the primary cause. To test whether coreceptor binding directly enhanced LCK kinase activity independently from pMHC binding, we repeated the ZAP70 membrane recruitment assay in unconjugated CD8-expressing HEK-TCR H cells. CD8 expression still enhanced the activity of LCK* (Fig. 7e and Supplementary Fig. 5b ), which we also found for CD4 (Fig. 7f and Supplementary Fig. 5c ), suggesting that both coreceptors use a similar mechanism to enhance LCK function.
The possibility remained that the observed results arose from a direct interaction of the coreceptors with the TCR complex itself, as previously suggested for CD4 (ref. 43 ). To test this hypothesis, we created chimeric coreceptors (CD86 Ex CD8 Int and CD86 Ex CD4 Int ) by substituting their extracellular domains with the monomer CD86 (ref. 44 ), while maintaining their interaction with LCK. Repeating the ZAP70 recruitment experiment with these constructs showed that the increased LCK* activity on coreceptor binding could be entirely attributed to the intracellular LCK* interaction (Fig. 7g,h and Supplementary Fig. 5d,e) . Furthermore, the coreceptor effect on LCK* function was almost completely attenuated when a larger fraction of LCK* was uncaged (Supplementary Fig. 5f-i) , which agrees with previous work that coreceptor enhancement of TCR signaling is only observed at physiologically low levels of ligand binding 45 .
DISCUSSION
By developing a means to both spatially and temporally activate tyrosine kinases in live cells, we have been able to quantitatively measure the kinetics of LCK catalytic activity in situ, with a level of control over kinase activity not readily achievable by conventional in vivo and in vitro approaches, as previously demonstrated 28 . In agreement with earlier biochemical studies [11] [12] [13] , we found that LCK can adopt a range of conformations that have a strong influence on its intrinsic kinase activity 46 . These conformations are primarily driven by intramolecular interactions mediated by both the regulatory SH2 and SH3 domains. We showed that the kinase activity of LCK* mutants Y505F, W97A and P232A were quantitatively equivalent ( Fig. 3d  and Supplementary Fig. 3c ), implying that they all biased the kinase structure to the same 'open' conformation. However, the concordance of reciprocal mutations affecting the SH3 intramolecular interaction a r t i c l e s (W97A and P232A) was not found for the equivalent SH2 interaction, in which the R154K mutation that disrupted this inhibitory interaction actually led to a decrease in activity. This suggested that the loss of LCK's ability to bind a phosphorylated substrate, likely the TCR itself in our assay, was more deleterious than decreased inhibition, perhaps because the intermolecular SH2 interaction also stabilizes the active conformation of the kinase domain 47, 48 .
Phosphorylation of the active-site loop of LCK leads to rearrangement and stabilization of the catalytic residues into their optimal positions and drives the full activation of the kinase 6, 7, 49 . We found that this phosphorylation was completely indispensable for LCK kinase activity, as the Y394F mutant was essentially inert in both of our in situ assays. This is at odds with a recent in vitro study 14 that found only a two-fold difference on Y394 phosphorylation, which could be explained by the additional constraints placed on LCK when localized to the plasma membrane. The kinetics of Y394 autophosphorylation were rapid, saturating approximately 1 min after LCK* photouncaging, which we hypothesize is required to ensure a kinetic advantage for LCK activation over the abundant phosphatases such as CD45 that would antagonize this modification 50 , as suggested previously 12 . This result was in striking contrast to the delayed ZAP70 autophosphorylation we measured, which could be rate limiting in TCR triggering and may have a role in ligand discrimination through kinetic proofreading. The decreased Y394 phosphorylation on a kinase-inactive version of LCK (K273R) suggested that LCK in an active, open conformation is a better substrate for autophosphorylation at Y394. This is supported by structural data of various inactive states of SRC kinase domains that show sequestration of Y394 within the active site, thus preventing its autophosphorylation 6 . A recent study had also suggested that a negative-feedback loop may control LCK activity through Y192 phosphorylation by ZAP70 (ref. 51) .
Finally, we found that the T-cell coreceptors have a stimulatory effect on LCK kinase activity, even in the absence of pMHC binding. This effect could be ascribed solely to the intracellular interaction between the coreceptors and LCK (Fig. 7) , a result that cannot easily be explained by current models of coreceptor function 45, 52 . We speculate that the physical interaction between LCK and the coreceptors induces a conformational rearrangement that enhances LCK function and implies that the unique SH4 domain of LCK could also form an intramolecular interaction that restrains kinase activity and that is released on coreceptor binding. Naturally, there are caveats to the approaches in this study. Although assaying kinase function within the cellular context provides a more physiological representation of the environment in situ, this means that the system is less 'clean' than true in vitro experiments, because endogenous proteins have the potential to affect our results. We used a nonimmune cell line to mitigate as many of these confounding effects as possible. Another limitation is that the absolute concentrations of the active enzyme and substrate cannot easily be determined, forcing us to measure relative rather than absolute enzyme kinetics. The extremely rapid autophosphorylation of LCK* at Y394 (Fig. 4) and ZAP70 recruitment to the plasma membrane by Y505F LCK* (Fig. 2e,h ) upon uncaging indicate that the presence of pc-Lys within the active site of LCK* did not result in a gross conformational change of the enzyme and that the observed kinetics reflect the true substrate phosphorylation kinetics rather than the recovery of kinase conformation upon uncaging.
In summary, our quantitative investigation of LCK kinase activity has provided new insights into how this important SFK functions, with the conclusions likely to translate to other members of the family. Furthermore, the effect of the coreceptors on LCK activity we observed showcases the power of measuring enzyme kinetics in situ, where the modulatory effect of membrane-bound interacting proteins can now be directly addressed. We demonstrated that this approach can be applied to other members of the SFK family ( Supplementary Fig. 4 ) and can easily be extended to many other kinases that contain a critical lysine within their active site, including ZAP70 kinase. Further developments to express the photocaged proteins in other more physiological cell types, such as primary T cells, are ongoing and will enable us to perform in vivo biochemistry experiments to modulate protein function with unprecedented spatiotemporal control.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Vector constructs. All constructs, unless described otherwise, were created by amplifying gene sequences using PCR, incorporating MluI and BamHI-STOPNotI restriction sites at the 5′ and 3′ ends of the gene, respectively. Following a double digestion with MluI and NotI, the PCR product was ligated into pHR-SIN lentiviral vector. Where required, a gene encoding a fluorescent protein was inserted in-frame between BamHI and NotI sites. All photocaged kinase constructs (WT and mutant LCK*, and SRC* and FYN*) were created by mutating the codon encoding for lysine in the active site of the kinase (K273 in LCK, K298 in SRC and K299 in FYN) to the amber (TAG) stop codon using overlap extension PCR. The SRC* sequence was gene synthesized (Thermo Fisher Scientific) to remove restriction sites by synonymous mutations. The modified genes along with gene encoding eGFP were inserted into pHR′ vector as described above.
The components required for UAA incorporation of photocaged lysine (pc-Lys) in proteins expressed by mammalian cells have been described previously 25, 29 . Briefly, the orthogonal pair of tRNA CUA (U25C) and aminoacyl-tRNA synthetase required to charge the tRNA CUA with photocaged lysine (pc-Lys) are encoded within a PiggyBac vector, (U6-PylT*) 4 -EF1α-PylRS. This plasmid contains four copies of the tRNA along with the synthetase, under the control of the U6 and EF1α promoter, respectively. The E55D mutant of eukaryotic release factor (eRF)-1 was additionally used to increase efficiency of pc-Lys incorporation.
For pHR-IFP2.0-CaaX, the IFP2.0 fluorescent protein was fused at the C terminus to the K-Ras prenylation sequence (LEKMSKDGKKKKKKSKTKCVIM). The gene was inserted between the BamHI and NotI of the pHR-SIN vector.
For pHCM-CD45RO, the gene for CD45RO (including an N-terminal His tag) was amplified from a published construct 53 . The SFFV promoter was replaced with the CMV equivalent. To drive high expression, the SV40 introns (16S) were synthesized as a GeneArt String and inserted as BssHII-MluI fragment at the 5′ end of CD45RO gene.
For pHR-CBP-2A-CSK, the genes for CBP and CSK were amplified from pHR-CBP and pHR-CSK 26 and inserted in-frame into a bicistronic vector with the P2A self-cleaving peptide sequence linking them.
For pHR-CD8(βα), the genes for CD8β and CD8α were amplified from genesynthesized fragments and inserted in-frame into a bicistronic vector with the P2A self-cleaving peptide sequence linking them.
For pHR-CD86 Ex CD4 Int and pHR-CD86 Ex CD8 Int , the chimeric sequences were gene synthesized (ThermoFisher Scientific) to fuse the extracellular domain of CD86 with the transmembrane domain and cytosolic tail of CD4 or CD8α. The synthesized genes were inserted into pHR vector as described above.
Cell culture. HEK-TCR and HEK-TCR H cell lines were created by lentiviral transduction of HEK-293T cell line (purchased from ATCC to ensure identity) to stably express 1G4 TCRαβ chains and CD3γδεζ chains as previously described 26 , sorted based on their cell surface expression and made clonal by limiting dilution. All HEK-cell variants were grown in DMEM (Sigma), and Raji B cells (purchased from ATCC) were grown in RPMI-1640 (Sigma), and both were supplemented with 10% FCS (Gibco), 2 mM l-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma). All cells were incubated at 37 °C, 5% CO 2 under full humidity and tested for mycoplasma contamination using MycoAlert kit (Lonza).
Transient transfection.
One day before transfection, HEK-293T cells were seeded into 6-well plates or 35 mm poly-l-lysine-coated glass-bottom imaging dishes (MatTek) so that the cells reached 75% confluency on the day of transfection. For all transfections performed here, a total of 2 µg of DNA per well or dish was transfected using GeneJuice (Merck), except for transfection of cells used in experiments presented in Figure 4b ,c, which was 1 µg of DNA per well. Transfected cells were usually analyzed 40-48 h after transfection.
In general, the main components to be transfected into HEK-TCR cells were pHR-LCK*, (U6-PylT*) 4 -EF1α-PylRS, pcDNA5-eRF1 (E55D) and pHR-ZAP70-mRuby2 at a DNA ratio of 2:2:2:1. Any additional components were included in the mix with a ratio of 1 while maintaining the total of 2 µg DNA per transfection. For microscopy experiments of unconjugated HEK cells, pHR-IFP2.0-CaaX was transfected in addition to the main components to identify plasma membrane. Biliverdin was added to the medium at 6 h after transfection at a final concentration of 20 µM to enhance IFP2.0 fluorescence. For microscopy experiments of HEK cells conjugated to Raji B cells, additional components of pHCM-CD45RO, pHR-CBP-2A-CSK and pHR-ICAM-1 were transfected in addition to the core LCK* components.
Lentiviral transduction and generation of stable expressing cells.
To produce lentivirus, the gene of interest in a lentiviral backbone vector, pCMV∆8.91 (encoding essential packaging genes) and pMD2.G (encoding VSV-G gene to pseudotype virus) were transfected into HEK-293T cells at a ratio of 2:2:1. A total of 1.5 µg of DNA was transfected per well using GeneJuice (Merck). After 48-72 h, the lentivirus-containing medium was collected, centrifuged at 4,300g for 2 min to remove debris, and incubated with HEK cells to be transduced for 16 h. Fresh medium was then added to the cells and expression of the protein of interest was monitored regularly, and the cell population was expanded. Once the expression level was stable, the cells were bulk sorted to isolate cell populations with the desired protein expression level.
Uncaging of LCK* by illumination for western blot analysis. After transfection for 40-48 h, HEK-TCR cells were trypsinized to detach them from the wells for 5 min at 37 °C and neutralized by the addition of an equal volume of fresh medium. Cells were pipetted several times to obtain a homogenous single-cell suspension and collected in a FACS tube after an aliquot was removed for analysis of protein expression by flow cytometry. The rest of the cells were then centrifuged at 800g for 5 min and the supernatant was discarded. Cells were washed once in sterile PBS and resuspended in an appropriate volume of DMEM gfp2 antibleaching medium (Evrogen) supplemented with 10% FCS.
Cells were illuminated with light from an AMH-200 light source (Andor) using a 'DAPI' (377 ± 25nm) filter at 2.5 or 12 mW/cm 2 for the specified illumination period. To facilitate this, a custom-designed illumination chamber was built around a Nikon Ti Epi-FL illuminator so that a tube could be positioned at the focal point of the illuminator while providing a means to sample the cells during illumination. Aliquots of cell suspension (50 µl) were collected at defined time intervals in 1.5-ml tubes prefrozen on a metal block with dry ice to immediately quench the phosphorylation reaction. An equal volume of 2× lysis buffer (2% Nonidet P40 (AppliChem), 2 mM sodium orthovanadate (Sigma), 2 mM phenylmethanesulfonylfluoride, and 2× Complete, EDTA-free protease inhibitor cocktail (Roche) in 2× Tris-buffered saline (40 mM Tris, 300 mM NaCl, pH7.4)) was overlaid on the frozen cell suspension, and the samples were thawed slowly on ice. After 1-h incubation on ice with occasional agitation to mix the samples, cell lysates were centrifuged at 20,000g for 10 min at 4 °C. The supernatant fraction was then mixed with LDS sample buffer and dithiothreitol and boiled at 95 °C for 10 min before analysis by SDS-PAGE and western blotting.
Western blotting. SDS-PAGE was performed using NuPAGE Novex 4-12% BisTris Midi protein gels (26 wells) and XCell4 SureLock Midi-Cell Electrophoresis System according to the manufacturer's instructions (Thermo Fisher Scientific). Gel transfer to nitrocellulose was performed using the iBlot device (Thermo Fisher Scientific). The primary antibodies used in this study were: anti-pY319-ZAP70 (cat#: 2701), anti-pY493-ZAP70 (cat#: 2704), anti-pY416-SRC (reacts with LCK pY394; cat#: 2101), anti-LCK (cat#: 2657), anti-SHP-1 (cat#: 3759), anti-SHP 2 (cat#: 3397) and anti-CSK mAb (cat#: 4980), which were all purchased from Cell Signaling Technology and are all raised in rabbit except anti-LCK, which was raised in mouse. Anti-beta actin mAb was raised in mouse (cat#: AB11003; Abcam). For the combined detection of LCK*, FYN* and SRC*, a mouse mAb against eGFP (cat#: A11120; Life Technologies) was used to give equivalent sensitivity. All primary antibodies were used at 1:1,000 dilution. Secondary antibodies were used at 1:20,000 dilution: anti-rabbit or mouse IgG (H+L) DyLight 800 (cat#: 5151 & 5257; Cell Signaling) and Alexa Fluor 680 goat anti-rabbit or mouse IgG (H+L) (cat#: A21109 & A21058; Life Technologies). The transferred blot membrane was first blocked with 2.5% nonfat milk (Sigma) in Tris-buffered saline (MTBS) before incubation with primary antibody in MTBS including 0.1% Tween-20 (MTBS-T) at 4 °C overnight with agitation. The membrane was then washed three times in TBS-T, then incubated for 1 h in the appropriate secondary antibody at room temperature in MTBS-T before being washed three times in TBS. Fluorescent protein bands were visualized using the Odyssey CLx imaging system (LI-COR) that enables two-color detection at 700 nm and 800 nm on the same blot over a >5-decade linear range. Cell conjugation. HEK-TCR cells for conjugation experiments were grown and transfected in 6-well plates as described above. After 40-48 h, cells were trypsinized to detach them from the wells for 5 min at 37 °C before neutralization by the addition of an equal volume of fresh medium. Cells were pipetted several times to obtain a homogenous single-cell suspension and collected in a 1.5-ml Eppendorf tube. Approximately 1 × 10 6 Raji B cells expressing the appropriate pMHC were collected in a separate tube. Both tubes were centrifuged at 800g for 3 min to pellet the cells. Resuspended pellets were then washed in fresh complete DMEM and centrifuged again. After centrifugation, both pellets were resuspended in residual medium and combined to a total volume of ~200 µl with medium in a 0.2-ml PCR tube. The cells were incubated in a 37 °C water bath for 30 min to drive cell conjugation. Following incubation, conjugated cells were washed once in Dulbecco's PBS with CaCl 2 and MgCl 2 (DPBS), resuspended in 1 ml of DMEM gfp2 anti-bleaching medium (Evrogen) and transferred to a MatTek imaging dish.
Spinning disc confocal microscopy. For imaging of unconjugated HEK cells to study ZAP70-mRuby2 recruitment to plasma membrane, cells were seeded directly into the imaging dish and transfected as described above. Prior to imaging, cells were washed gently in DPBS once and 1 ml of imaging medium was added to cover the cells in the dish. All live-cell-imaging experiments in this study used a Nikon Ti inverted microscope in a thermally controlled enclosure (OKOLabs), equipped with a CSU-X1 spinning-disc confocal head (Yokogawa). Laser lines used to excite samples were: 405 nm (100 mW), 488 nm (60 mW), 561 nm (50 mW) and 640 nm (100 mW), controlled by an acoustooptic tunable filter (Andor). Fluorescence emission was collected through filters for mTagBFP (460 ± 15 nm), eGFP (525 ± 25 nm), mRuby2 (607 ± 18 nm) and IFP2.0 (708 ± 38 nm). All images were collected using a Plan Apo VC 100 × 1.4 NA oil-immersion objective (Nikon) onto an iXon Ultra EM-CCD camera (Andor) with a calculated pixel size of 85 nm. Stage movement was controlled by a Prior motorized stage with a Piezo Z-drive. The entire microscope system was controlled by µManager software that was used to create multichannel, multitime-point image data sets and at multiple positions when required. The built-in perfect-focus unit of the microscope was used to correct for axial focus drift due to fluctuations in temperature.
Global photo-uncaging. HEK cells expressing both LCK* and ZAP70-mRuby2 were identified under the microscope based on the expression of the tagged fluorescent proteins. In the cell-conjugation experiment, conjugated cells were identified based on the presence of pMHC-BFP-expressing Raji B cells forming a cup-shaped contact with LCK* and ZAP70-mRuby2-expressing HEK cells. To follow ZAP70-mRuby2 recruitment to the plasma membrane or cell-conjugate interface after LCK* activation, cells were illuminated by light from an AMH-200 light source (Andor) through a DAPI filter cube (excitation at 377 ± 25 nm) in the microscope. A script was written in µManager software to capture 5-10 images before photouncaging by illuminating cells through the objective at 5 mW/cm 2 or 500 mW/cm 2 for a duration of 2 s. Following this, images were acquired continuously every ~1.4 s for approximately 2 min. Images from all relevant fluorescence channels were captured throughout the experiment. Images were analyzed as described below. Acquisition parameters were set up to ensure the best dynamic range to avoid signal saturation in the fluorescence channels. Owing to variability in the expression of proteins using transient transfection, individual laser powers were adjusted between experiments while maintaining the exposure times.
Focused photouncaging. To activate LCK* spatially with subcellular accuracy in the cell-cell conjugate region, a similar protocol was used as for the global photouncaging. To uncage LCK*, a defined diffraction-limited spot in the image was excited with a 405-nm laser at full power (1.2 mW at objective), using a dwell-time of 100 µs repeated 10 times. Images were subsequently acquired as described above.
Data analysis. Western blot images. High resolution western blot images from the Odyssey imager were acquired as 32-bit grayscale files for quantification with ImageJ software. Equivalent regions of interest (ROIs) were drawn around the bands of interest to measure the integrated density of each ROI. To express the level of phosphorylation relative to LCK*, to correct for loading and expression, the density value of the phosphorylated band was divided by that of the corresponding LCK* band to obtain the relative phosphorylation of each sample. To allow comparison between experiments, these values were then normalized according to the figure legends to create a plot of phosphorylation kinetics. For every experiment, a WT data set was also collected so that different conditions could be directly compared through this standard. Further processing of the western blots shown in figures (rotation, cropping and contrasting) was performed uniformly over images solely for better visualization. Where needed, white dotted lines denote sections of the same blot with different contrast settings for visual clarity only. Image quantification, however, always used the values from original image files.
Microscopy images. Processing and quantitative analyses of microscopy images were performed using scripts written in ImageJ. Data from the ZAP70-mRuby2 channel were corrected for photobleaching before quantification, which followed a single-exponential decay process. ROIs were drawn around the cell edge or the cell-conjugate region to measure the signal for ZAP70-mRuby2 recruitment to these regions over time. To define the plasma membrane ROIs, images from the ZAP70-mRuby2, LCK*, and IFP2.0-CaaX stacks were combined, background subtracted and contrast enhanced to clearly define a cell shape that could be thresholded to create a binary mask of the cell. This mask was then outlined to describe the cell edge as a single-pixel-width ROI, which was remapped to the range [0, 1]. The pixel count in the ROI was used as the mask area. To draw an ROI in the cell-conjugate region, the images from the pMHC-BFP channel were used. Prior to quantification, where needed, image stacks were cropped to isolate the relevant conjugated cells to remove signal from nearby unconjugated cells. Upon background subtraction, contrast enhancement and Gaussian smoothing, the conjugate region was thresholded to create a binary mask. This mask was skeletonized to create a single-pixelwidth ROI and mapped over [0, 1] . The masked images and corresponding ZAP70-mRuby2 stack were then multiplied to create a stack that only contained the fluorescence intensity values in the ROI only. To obtain the mean value of mRuby2 intensity in the ROI, the summed intensities were divided by the ROI area. A similar workflow was performed to obtain the mean value of mRuby2 over the entire cell by drawing an ROI of the area bounded by the cell mask. The mean intensity at the cell edge or conjugate region was divided by the corresponding mean intensity over the whole cell to obtain the relative fraction for ZAP70 membrane or conjugate recruitment in each image, plotted against time in the main text. To measure the ratio of eGFP signal inside over outside the conjugate, line ROIs were drawn manually to define the conjugate region and the edge of eGFP-expressing HEK cells before illumination. Mean intensities of eGFP were then measured at these ROIs.
Quantification of endogenous protein expression. Expression of endogenous CSK, SHP-1 and SHP-2 in various cell lines was detected by western blot using monoclonal antibodies specific to the proteins. Samples were prepared as described for the main experiment, and the blots were analyzed as described above. Three different dilutions of each soluble cell lysate were measured to obtain an average value. Raw intensity values from the blots were corrected for the dilution factors obtained from the relative expression of an actin control, cell density in sample and the cytoplasmic volumes of the specific cell lines. These corrected values for each cytoplasmic protein are then presented as relative values compared to the protein expression in CD4 + T cells. Cytoplasmic volumes of the different cell lines were 96.1 fL for CD4 + and CD8 + T cells, 664 fL for Jurkat T cells and 790 fL for HEK293T cells [54] [55] [56] .
Data plotting. All data were initially processed in Excel (Microsoft) to compute the mean and s.e.m. values. Subsequent data plotting was performed using MATLAB (MathWorks). Where appropriate, data fitting was performed using a three-parameter logistic function: where b is the Hill's coefficient, c is the inflection point, d is the maximum asymptote and t is time (min).The maximum asymptote values calculated were used for normalization of the imaging data in Figure 7 , and the derived 95% confidence interval values were used as the error bar values in Figure 4d . Otherwise, a moving-average filter was used to smooth the data points. Error bars were used to represent the s.e.m. of discrete data points in phosphorylation analyses. Filled area was used to represent the s.e.m. of the more continuous data points in the ZAP70 recruitment analyses.
Derivation of relative initial rates and time to half-maximal ZAP70 recruitment. Plots from western and imaging data were analyzed by MATLAB (MathWorks) further to derive a measure of the rate of LCK kinase activity in each experiment. For the Western analyses, the reaction rate was estimated by differentiating the three-parameter logistic function used to fit the data (see data plotting above) with respect to time. Taking this value at t = 0.5 min defined the initial reaction rate (V 0 ), when this parameter is expected to be maximal immediately after end of the photouncaging period. For the imaging experiments, the ZAP70-recruitment data sets were smoothed and normalized to the corresponding maximum values for data sets that had reached saturation or maximum asymptotes for data sets that had not. The normalized data were then spline fitted to estimate the time when the recruitment of ZAP70 to the plasma membrane was at half-maximum. In both cases, rate parameters were determined from n number of independent experiments as indicated in the figure legends, and the mean and s.e.m. values were calculated from these values.
Data availability. Source data used to generate all graphs presented in this study are available in Supplementary Data Set 2. Other data that support the findings of this study (for example, microscopy images and prenormalization raw values) are available from the corresponding author upon reasonable request. A Life Sciences Reporting Summary for this article is available online.
